Hims Hers Health Inc
For the period ended Dec 31, 2024. Filed Feb 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 24, 2025
HIMS$19.13-16.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
(In Thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Operating activities | |||
| Net income (loss) | $126,038 | $(23,546) | $(65,678) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 17,088 | 9,515 | 7,474 |
| Stock-based compensation | 92,322 | 66,080 | 42,817 |
| Change in fair value of liabilities | — | 1,075 | (70) |
| Net (accretion) amortization on securities | (4,355) | (5,686) | 146 |
| Benefit for deferred taxes | (61,649) | (13) | (594) |
| Impairment of long-lived assets | 114 | 429 | 1,127 |
| Non-cash operating lease cost | 2,546 | 1,922 | 1,605 |
| Non-cash acquisition-related costs | — | 2,691 | 837 |
| Non-cash other | 357 | 195 | — |
| Changes in operating assets and liabilities: | |||
| Inventory | (41,612) | (902) | (8,004) |
| Prepaid expenses and other current assets | (9,494) | (6,395) | (6,335) |
| Other long-term assets | (56) | (58) | 17 |
| Accounts payable | 43,710 | 7,324 | 12,723 |
| Accrued liabilities | 23,791 | 16,524 | 909 |
| Deferred revenue | 67,552 | 6,261 | (1,716) |
| Operating lease liabilities | (2,443) | (1,933) | (1,605) |
| Earn-out payable | (2,825) | — | (10,184) |
| Net cash provided by (used in) operating activities | 251,084 | 73,483 | (26,531) |
| Investing activities | |||
| Purchases of investments | (160,564) | (157,239) | (187,700) |
| Maturities of investments | 208,940 | 170,051 | 194,259 |
| Proceeds from sales of investments | 725 | 1,574 | 35,846 |
| Investment in website and mobile application development and internal-use software | (11,095) | (9,272) | (4,533) |
| Purchases of property, equipment, and intangible assets | (41,655) | (17,220) | (2,714) |
| Acquisition of business, net of cash acquired | (15,399) | — | — |
| Deferred consideration paid for acquisitions | — | — | (459) |
| Net cash (used in) provided by investing activities | (19,048) | (12,106) | 34,699 |
| Financing activities | |||
| Proceeds from exercise of vested stock options | 26,651 | 2,322 | 2,246 |
| Payments for taxes related to net share settlement of equity awards | (52,501) | (14,096) | (3,901) |
| Repurchases of common stock | (83,039) | (1,999) | — |
| Payments for acquisition-related earn-out consideration | (3,190) | — | (32,650) |
| Proceeds from employee stock purchase plan | 3,901 | 2,298 | 1,178 |
| Proceeds from exercise of Class A common stock warrants | 333 | — | — |
| Net cash used in financing activities | (107,845) | (11,475) | (33,127) |
| Foreign currency effect on cash and cash equivalents | (270) | (11) | (53) |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 123,921 | 49,891 | (25,012) |
| Cash, cash equivalents, and restricted cash at beginning of period | 97,519 | 47,628 | 72,640 |
| Cash, cash equivalents, and restricted cash at end of period | $221,440 | $97,519 | $47,628 |
| Reconciliation of cash, cash equivalents, and restricted cash | |||
| Cash and cash equivalents | $220,584 | $96,663 | $46,772 |
| Restricted cash | 856 | 856 | 856 |
| Total cash, cash equivalents, and restricted cash | $221,440 | $97,519 | $47,628 |
| Supplemental disclosures of cash flow information | |||
| Cash paid for taxes | $7,916 | $1,109 | $636 |
| Non-cash investing and financing activities | |||
| Purchases of property and equipment included in accounts payable and accrued liabilities | 7,781 | 3,383 | — |
| Right-of-use asset obtained in exchange for lease liability | 2,593 | 6,270 | 1,206 |
| Vesting of early exercised stock options | — | — | 197 |
| Issuance of common stock for acquisition-related earn-out consideration | 1,396 | — | — |
| Issuance of common stock and liabilities assumed in connection with acquisition of business | 16,000 | — | — |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.